VA plans research on using psychedelics to treat PTSD, depression

Veterans Affairs leaders plan to launch new studies on the use of psychedelic compounds to treat post-traumatic stress disorder and depression in veterans, the first such scientific work by the department on the substances since the 1960s.

The move comes amid a growing body of research on the positive impact of compounds like methylenedioxymethamphetamine (MDMA) and psilocybin in helping with mental health issues. However, department officials said that work so far has largely excluded veterans, and more specific investigation is needed into how those alternative treatments may positively or negatively affect them.

“Veterans and VA researchers have told us about the potential promise of psychedelics to treat mental health conditions for some time,” VA Under Secretary for Health Dr. Shereef Elnahal said in a statement released Friday. “Now is our chance to study this potential method of treating veterans with PTSD and major depression across the country.”

Department officials did not say when the new studies will begin or when psychedelics may be approved for broader use in veterans’ mental health care. Friday’s announcement by VA leaders was designed to begin soliciting study proposals from its network of researchers and academic institutions.

RELATED

First-ever provision for psychedelic studies included in defense bill

Any member of the military with either post-traumatic stress disorder or traumatic brain injury can take part in a clinical study.

By Zamone Perez

VA researchers have already conducted a limited number of studies on psychedelics in federal facilities, but those did not use department funding. The new VA-backed efforts will look at “the effectiveness and safety of using MDMA and psilocybin-augmented psychotherapy in veterans,” according to a department release.

Last September, federal clinicians, scientists and policy makers gathered in Denver to discuss the topic of medical psychedelic use and the potential for integrating them into VA care. Lawmakers have also taken steps in recent months to mandate further study of the compounds’ benefits for troops and veterans, with bipartisan support for the idea.

Language in draft proposals of the annual VA appropriations bill pending before Congress would mandate pilot programs for therapies, including MDMA. As part of the recently passed annual defense authorization bill, Congress required the Defense Department launch new studies this year to analyze the effects of psychedelics on troops suffering from various medical issues.

In a statement, VA Secretary Denis McDonough said the move represents “an important step to explore the efficacy of a potential new set of promising treatments that could improve the health and quality of life for veterans.”

Department officials said that despite the upcoming interest in the potential benefits from psychedelics, veterans should not use them as part of a self-treatment program.

In Other News

What do you think of your boss? Are you paid enough? OPM wants to know

Feds will soon begin receiving emails to take the 2024 Federal Employee Viewpoints Survey.

Ask Reg: I may want to come out of retirement. What would my status be?

Just because you have previous federal service doesn't mean you can reapply as a "status" candidate.

What you need to know about transitioning out of the military

Getting out of the military? Here's what you need to know.

FY25 defense budget work to ramp up after security supplemental finish

Defense and veterans hearings on Capitol Hill for the week of April 30, 2024.

Austin calls European allies, seeking more Patriots for Kyiv

The U.S. secretary of defense has held multiple one-on-one calls with European allies this week, during which he raised the topic.

Load More